What is the translation of " DESCRIBED IN TABLE " in Slovenian?

[di'skraibd in 'teibl]
[di'skraibd in 'teibl]
opisano v preglednici
described in table
opisano v tabeli
described in table
outlined in table
opisane v preglednici
described in table
opisani v tabeli
described in table

Examples of using Described in table in English and their translations into Slovenian

{-}
  • Financial category close
  • Medicine category close
  • Colloquial category close
  • Official category close
  • Ecclesiastic category close
  • Computer category close
  • Official/political category close
  • Programming category close
Dose modifications due to peripheral neuropathy are described in Table 1.
Spremembe odmerka zaradi periferne nevropatije so opisane v Tabeli 1.
The steps and hypothesis described in table 6 of EN50388:2005 have to be defined by the applicant(column 3 not applicable), taking into consideration input data given in Annex D of the same standard;
Korake in hipoteze, opisane v preglednici 6 standarda EN 50388_2005, mora opredeliti prosilec(stolpec 3 se ne uporablja) ob upoštevanju vnesenih podatkov iz Priloge D istega standarda;
Changes in selected laboratory parameters are described in Table 4.
Spremembe izbranih laboratorijskih vrednosti so opisane v preglednici 4.
The haircuts differ according to the residual maturity, type of interest payment( fixed or variable) and the valuation methodology applied by the national central bank( see Section 6.5),as described in Table 9.---.
Višina odbitka pri vrednotenju je odvisna od preostale dospelosti, vrste plačila obresti( fiksna ali variabilna obrestna mera) in metodologije vrednotenja, ki jo uporablja NCB( glej poglavje 6.5),kot je opisano v tabeli 9.
A maximum of two consecutive dose reductions for each medicinal product, as described in Table 1, can be applied in case of toxicity.
V primeru toksičnosti se lahko uporabita največ dva zaporedno zmanjšana odmerka za posamezno zdravilo, kot je opisano v Preglednici 1.
The starting dose of methoxy polyethylene glycol- epoetin beta is based on the calculated previous weekly dose of darbepoetin alfa orepoetin at the time of substitution as described in Table 1.
Začetni odmerek metoksipolietilenglikol epoetina beta je izračunan na osnovi prejšnjega tedenskega odmerka darbepoetina alfa ali epoetina ob času zamenjave,kot je opisano v preglednici 1.
The haircuts differ according to the residual maturity andcoupon structure of the debt instruments as described in Table 7 for eligible marketable fixed coupon and zero coupon debt instruments( 42).
Višina odbitka pri vrednotenju je odvisna od preostale dospelosti in strukture kupona dolžniškega instrumenta,kot je opisano v tabeli 7 v zvezi z dolžniškimi instrumenti s fiksnim kuponom in brezkuponskimi instrumenti( 42).
Re-initiation of treatment should occur once the QTc decreases below 500 ms andat a lower dose as described in table 2.
Zdravljenje se sme znova začeti, ko se interval QTc skrajša pod 500 ms; uporabiti je treba manjši odmerek,tako kot je opisano v preglednici 2.
Fishing in the Regulatory Area shall be restricted to anarea east of a line bound by the coordinates described in Table 3 and depicted in Figure 1(3) of the CEM referred to in point 8 of the Annex to this Regulation.
Ribolov na upravnem območju je omejen na območjevzhodno od črte, ki povezuje koordinate, opisane v preglednici 3 in prikazane na sliki 1(3) ukrepov za ohranjanje in izvrševanje iz točke 8 Priloge k tej uredbi.
The EC verificationshall be performed in accordance with the module(s) described in Table 6.
ES-verifikacija se izvede v skladu z moduli, opisanimi v preglednici 6.
The active substance in Recocam 20 mg/ml solution for injection for cattle,pigs and horses is an allowed substance as described in table 1 of the annex to Commission Regulation(EU) No 37/2010:.
Zdravilna učinkovina v zdravilu Recocam je dovoljena snov,kot je navedena v tabeli 1(dovoljene snovi) Priloge Uredbe Komisije(EU) št.
Treatment should be withheld in patients who develop a QTc interval greater than 500 msec on at least 2 separate ECGs until the QTc interval is less than 481 msec or recovery to baseline if the QTc interval is greater than or equal to 481 msec,then resume TAGRISSO at a reduced dose as described in Table 1.
Prekinite uporabo pri bolnikih, ki se jim interval QTc podaljša preko 500 msec na vsaj 2 ločenih posnetkih EKG, in ga ne uporabljajte, dokler ni interval QTc manj kot 481 msec oziroma do njegove vrnitve na izhodiščno vrednost, če je izhodiščni interval QTc 481 msec ali več. Potem začnite zdraviloTAGRISSO znova uporabljati v manjšem odmerku, tako kot je opisano v preglednici 1.
Changes in selected laboratory parameters are described in Table 4.
Spremembe izbranih laboratorijskih parametrov so opisane v preglednici 4.
The haircuts differ according to the residual matu rity, type of interest payment( fixed or variable), the credit quality category and the valuation methodology applied by the NCB(see Section 6.5), as described in Table 9(*).
Višina odbitka je odvisna odpre ostale zapadlosti, vrste plačila obresti( fiksna ali variabilna obrestna mera), bonitetne kategorije in metode vredno tenja, ki jo uporablja NCB( glej oddelek 6.5),kakor je opisano v tabeli 9(*).
Post-hoc survival analyses were undertaken thereafter as described in table 7.
Zatem so naredili post-hoc analizo preživetja, kot je opisano v preglednici 7.
The starting dose of MIRCERA is based on the calculated previous weekly dose of darbepoetin alfa orepoetin at the time of substitution as described in Table 1.
Začetni odmerek zdravila MIRCERA je izračunan na osnovi prejšnjega tedenskega odmerka darbepoetina alfa ali epoetinaob času zamenjave, kot je opisano v preglednici 1.
Changes in selected laboratory values during therapy are described in Table 8.
Spremembe izbranih laboratorijskih vrednosti so opisane v preglednici 4.
The valuation haircuts applied to all marketable inverse floating rate debt instruments are thesame for all liquidity classes and are described in Table 8.
Odbitki pri vrednotenju, ki se uporabljajo za vse tržne dolžniške instrumente z obratno spremenljivo donosnostjo,so enaki za vse likvidnostne kategorije in so opisani v tabeli 8.
The verification documentation required for each scheme is described in Table 7.1.
Dokumentacija o preverjanju, ki se zahteva za posamezno shemo, je opisana v preglednici 7.1.
The valuation haircuts applied to all marketable inverse floating rate debt instruments included in categories I to IV are thesame and are described in Table 8.
Odbitki pri vrednotenju, ki se uporabljajo za vse tržne dolžniške instrumente z obratno spremenljivo donosnostjo v kategorijah od I do IV,so enaki in so opisani v tabeli 8.
This table is intended to specify data to be collected inrelation to the research surveys at sea that are described in Table 1G of this Annex.
V njej so navedeni podatki, ki jih je treba zbirativ zvezi z raziskavami na morju in ki so navedeni v tabeli 1G te priloge.
( e) the third, fourth and fifth indents are replaced by the following:«--- The valuation haircuts applied to all marketable inverse floating rate debt instruments included in categories I to IVare the same and are described in Table 8.
( e) Tretja, četrta in peta alinea se nadomestijo z naslednjim:„--- Odbitki pri vrednotenju, ki se uporabljajo za vse tržne dolžniške instrumente z obratno spremenljivo donosnostjo v kategorijah od I do IV,so enaki in so opisani v tabeli 8.
The virologic response rates of the 41 subjects transplanted with HCV RNA<LLOQ is described in Table 17.
Stopnje virološkega odziva za prvih 41 oseb s presaditvijo, z RNA HCV< LLOQ,so navedene v preglednici 17.
Adverse drug reactionsidentified during the post-marketing experience with Caelyx are described in Table 9.
Neželeni učinki, ugotovljeniv obdobju trženja zdravila Caelyx, so opisani v preglednici 9.
The Commission notesthat this latter investment plan comprises part of the investments described in Tables 5-8.
Komisija ugotavlja, data nazadnje omenjeni investicijski načrt zajema del investicij, opisanih v Tabelah 5 do 8.
Dose reductions are recommended for severe or persistent neutropenia andthrombocytopenia as described in Table 1:.
Zmanjšanje odmerka je priporočljivo pri hudi ali dolgotrajni nevtropeniji in trombocitopeniji,kot je opisano v preglednici 1:.
Dose adjustments in 100 mg steps per day(i.e. a 50 mg reduction per dosing)based on individual safety and tolerability are recommended as described in Table 1 and Table 2.
Priporočljivo je postopno prilagajanje odmerka po 100 mg na dan(to je zmanjšanje za 50mg na odmerek) na podlagi individualne varnosti in prenašanja, kot je opisano v preglednicah 1 in 2.
For multiple myeloma patients treated with Caelyx in combination with bortezomib who experience PPE or stomatitis,the Caelyx dose should be modified as described in Table 1 and 2 above respectively.
Pri bolnikih z multiplim mielomom, ki se zdravijo z zdravilom Caelyx v kombinaciji z bortezomibom in dobijo palmarno- plantarnoeritrodisestezijo(PPE) oziroma stomatitis, je treba odmerek zdravila Caelyx prilagoditi, kot je opisano v Preglednicah 1 in 2 zgoraj.
The haircuts are applied by deducting a certain percentage from the market value of the underlying asset. The haircuts applied to debt instruments included in categories I to IV differ according to the residual maturity andcoupon structure of the debt instruments as described in Table 7 for eligible marketable fixed coupon and zero coupon debt instruments.
Višina odbitka pri vrednotenju, ki se uporablja pri dolžniških instrumentih v kategorijah od I do IV, je odvisna od preostale zapadlosti in strukture kupona dolžniškega instrumenta, kotje za primerne tržne dolžniške instrumente s fiksnim kuponom in brez kupona opisano v tabeli 7.
( b) the third sentence of the second indent of the first paragraph is replaced by the following:« The haircuts applied to debt instruments included in categories I to IV differ according to the residual maturity andcoupon structure of the debt instruments as described in Table 7 for eligible marketable fixed coupon and zero coupon debt instruments(*).
( b) Tretji stavek druge alinee v prvem odstavku se nadomesti z naslednjim:„Višina odbitka pri vrednotenju, ki se uporablja pri dolžniških instrumentih v kategorijah od I do IV, je odvisna od preostale zapadlosti in strukture kuponadolžniškega instrumenta, kot je za primerne tržne dolžniške instru mente s fiksnim kuponom in brez kupona opisano v tabeli 7(*).
Results: 30, Time: 0.0491

Word-for-word translation

Top dictionary queries

English - Slovenian